Artiva Biotherapeutics announces annual shareholder meeting

• Artiva Biotherapeutics will hold its annual stockholders meeting virtually on Sept. 8, 2026.
• Shareholders will vote to elect two Class II directors, including Brian Daniels and Laura Stoppel.
• The meeting will also vote on ratifying KPMG as independent auditor for the year ending Dec. 31, 2026.
• A separate proposal seeks approval to amend the 2024 Equity Incentive Plan, adding 5,097,095 shares to the share reserve.
• The amendment would also include shares underlying pre-funded warrants in the plan’s annual share reserve increase calculation.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Artiva Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-330563), on August 03, 2026, and is solely responsible for the information contained therein.